Atlas Trials

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Clinical trial NCT00287248 · COMPLETED

Trial details

NCT number
NCT00287248
Sponsor
Institute for Neurodegenerative Disorders
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2006-02-01
Primary completion
2008-02-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.